Jp. Defaux et al., INVOLVEMENT OF PLATELET-ACTIVATING-FACTOR (PAF) IN ENDOTOXIN-INDUCED OR ISCHEMIA-INDUCED INTESTINAL HYPERPERMEABILITY IN THE RAT, Journal of lipid mediators, 7(1), 1993, pp. 11-21
We have investigated the influence of BN 50727, a PAF antagonist, and
allopurinol, a free radical scavenger, on the damaging effects of isch
aemia-reperfusion and endotoxin in the small intestinal mucosa. Using
a rat experimental model, we determined the alterations in intestinal
permeability and mucosal levels of PAF and lysoPAF following ischaemia
or intravenous administration of endotoxin. Both of these treatments
increased intestinal permeability and enhanced PAF levels in the mucos
a. Preventive oral or intraduodenal administration of BN 50727 reduced
both of these effects, by decreasing mucosal PAF formation, probably
as a result of neutrophil infiltration and activation reduction. Pretr
eatment of the rats with allopurinol also resulted in similar protecti
on except that the free radical scavenger was unable to inhibit the in
crease in PAF levels after ischaemia, suggesting that oxidative reagen
ts are implicated in this pathology to a much greater extent than PAF.